The histopathological and electrophysiological effects of thymoquinone and methylprednisolone in a rabbit traumatic facial nerve paralysis model

Abstract Objective We aimed to determine the effects of methylprednisolone and thymoquinone on nerve healing in a traumatic facial nerve paralysis animal model. Subjects and methods Twenty-four rabbits were randomly divided into 4 groups: group I: control group received no medication and no trauma;...

Full description

Saved in:
Bibliographic Details
Published in:American journal of otolaryngology 2016-09, Vol.37 (5), p.407-415
Main Authors: Sereflican, Murat, Yurttas, Veysel, Ozyalvacli, Gulzade, Terzi, Elcin Hakan, Turkoglu, Sule Aydin, Yildiz, Serpil, Ilgaz, Yasin, Seyhan, Sinan, Oral, Mesut, Dagli, Muharrem
Format: Article
Language:English
Subjects:
Animals
Bells palsy
Benzoquinones - therapeutic use
Disease Models, Animal
Electrodes
Electromyography
Facial Nerve Injuries - complications
Facial Nerve Injuries - pathology
Facial Nerve Injuries - physiopathology
Facial Paralysis - drug therapy
Facial Paralysis - etiology
Facial Paralysis - pathology
Male
Methylprednisolone - therapeutic use
Nerve Regeneration
Neuroprotective Agents - therapeutic use
Otolaryngology
Rabbits
Recovery of Function
Studies
Surgery
Trauma
Values
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective We aimed to determine the effects of methylprednisolone and thymoquinone on nerve healing in a traumatic facial nerve paralysis animal model. Subjects and methods Twenty-four rabbits were randomly divided into 4 groups: group I: control group received no medication and no trauma; group II: sham group received no medication after facial nerve trauma group III: 5 mg/kg/day thymoquinone administered; group IV: 1 mg/kg/day methylprednisolone administered. An initial electrophysiological assessment was performed in all the animals. The buccal branch of the facial nerve was then clipped to form a traumatic facial paralysis model. The drugs were administered for two weeks once a day. At the end of the second month, the electrophysiological assessments were performed and the distal part of the traumatic facial nerve were dissected and examined under light microscopy. Results Best nerve regeneration was observed in the control and the thymoquinone groups, respectively, whereas the weakest regeneration was determined in the sham group. Thymoquinone and methylprednisolone significantly increased nerve recovery, as measured by histopathological scores and electrophysiological assessment. In the thymoquinone group, due to postoperative amplitude, axon diameter and thickness of myelin sheath values were significantly further increased nerve regeneration compared to that of the methylprednisolone group and these values were close to those of the values of the control group. Conclusion Thymoquinone was slightly better than methylprednisolone for functional nerve recovery. The neuroprotective effect of thymoquinone was attributed to its antioxidant and anti-inflammatory effects. Thymoquinone can have a new treatment option to ameliorate the nerve injury.
ISSN:0196-0709
1532-818X
DOI:10.1016/j.amjoto.2016.05.006